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Intermittent parathyroid hormone 
1–34 induces oxidation and 
deterioration of mineral and 
collagen quality in newly formed 
mandibular bone
Yohsuke Yoshioka  1, Eiki Yamachika2, Makoto Nakanishi3, Tadashi Ninomiya4, sho Akashi1, 
sei Kondo1, Norifumi Moritani1, Yasuhiro Kobayashi5, Tatsuo Fujii3 & Seiji Iida1
Intermittent parathyroid hormone (PTH) administration is known to promote bone healing after 
surgical procedures. However, the mechanism and influence of PTH on the mineral and collagen quality 
of the jaw are not well understood. Most studies have focused on analyzing the bone density and 
microstructure of the mandible, and have insufficiently investigated its mineral and collagen quality. 
Oxidative stress activates osteoclasts, produces advanced glycation end products, and worsens mineral 
and collagen quality. We hypothesized that PTH induces oxidation and affects the mineral and collagen 
quality of newly formed mandibular bone. To test this, we examined the mineral and collagen quality 
of newly formed mandibular bone in rats administered PTH, and analyzed serum after intermittent 
PTH administration to examine the degree of oxidation. PTH administration reduced mineralization 
and worsened mineral and collagen quality in newly formed bone. In addition, total anti-oxidant 
capacity in serum was significantly decreased and the oxidative-INDEX was increased among PTH-
treated compared to vehicle-treated rats, indicating serum oxidation. In conclusion, intermittent 
administration of PTH reduced mineral and collagen quality in newly formed mandibular bone. This 
effect may have been induced by oxidation.
Bone strength is evaluated from bone density and bone quality, where bone quality is defined by its structural 
and material characteristics1. Structural characteristics are evaluated based on the macroscopic structure of bone, 
the microscopic structure of cancellous trabecular bone, and cortical bone porosity. In contrast, material char-
acteristics are evaluated based on the extent of mineralization, mineral quality, and collagen quality1,2. While the 
structural characteristics of bone substantially depend on remodeling, material characteristics vary markedly 
according to oxidative stress, in addition to bone remodeling3,4. Oxidative stress stimulates the differentiation and 
active factors of osteoclasts, and induces the production of advanced glycation end products (AGEs), which cause 
a deterioration in material characteristics3,4.
Intermittent administration of parathyroid hormone (PTH) causes high bone turnover with superior osteo-
genesis, and thereby increases bone density and improves the structural characteristics of the femur and spine. 
Intermittent administration of PTH has therefore been adopted for the treatment of osteoporosis5. Many clinical 
and animal studies indicate that intermittent administration of PTH promotes bone healing6–9. In addition to 
improving bone density and the structural characteristics of newly formed vertebrae and long bone after injury, 
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which are formed by endochondral ossification6,7, intermittent administration of PTH also improves bone 
density and the structural characteristics of newly formed uninjured skull and jaw bone, which is formed by 
intra-membranous ossification8,9. However, the effect of intermittent administration of PTH on the material char-
acteristics of new bone is unclear. To our knowledge, the only study to have reported the influence of PTH on 
these characteristics was conducted in a tibial fracture model10, and showed that PTH altered the material char-
acteristics of the newly formed tibia bone10. However, the effect of PTH administration on the material character-
istics of newly formed jawbone, which has a different ossification mode from the tibia, is unclear. In addition, the 
jaw characteristically differs from other bones, exhibiting faster bone turnover and experiencing stronger forces, 
such as occlusal forces. Accordingly, drugs may have a different impact on the jaw compared to other bones.
Improving surgical outcomes in the maxillofacial area requires an understanding of bone quality11–13. This 
is especially true for dental implant surgery: in these procedures, surgical success is greatly dependent on bone 
quality, and an understanding of bone mass and bone quality is therefore indispensable12,13. Because the bone 
mass and bone quality of the jaw are deteriorated in patients with osteoporosis, dental implant treatment in 
these patients is limited, and the success rate of dental implant treatment is reportedly low14,15. Life expectancy 
is increasing however, and the need for dental implant surgery in these patients is expected to increase. Several 
studies have therefore aimed to improve depreciated bone mass and bone quality using PTH administration16,17. 
PTH increases bone mass and improves its structural characteristics, and is expected to increase the availability 
of dental implant treatment and enable stable osseointegration after dental implant surgery16,17. However, the 
effect of PTH administration on the material characteristics of newly formed bone in the jaw is currently unclear. 
Integration of a dental implant into existing bone can be achieved by intervening in bone formation and the ongo-
ing bone healing process. Adapting PTH to implant treatment therefore requires a precise understanding of the 
effect of PTH on both the structural and material characteristics of newly formed jawbone.
Raman microspectroscopy is a powerful tool for analyzing the material characteristics of bone. The Raman 
microspectroscope is a non-contact, non-destructive, and label-free device, and the technique requires few 
pre-treatments of bone samples to comprehensively analyse specific molecules. Raman spectroscopy can be used 
to multilaterally evaluate the material characteristics of bone by measuring several parameters, including the 
degree of calcification, crystallinity, concentration of carbonates and phosphates, and completeness of the colla-
gen structure18–20.
In this study, we analyzed the effect of PTH on the balance between oxidative stress and anti-oxidant capacity, 
and demonstrated its influence on the material characteristics of new mandibular bone.
Materials and Methods
All animal studies were approved by the Institutional Animal Care and Use Committee of Okayama University, 
and experiments conformed to all guidelines and regulations for the protection of welfare of animals (protocol 
No. OKU-2018325).
Animals. The experimental protocol is shown in Fig. 1a. A total of 12 female Wistar ovariectomized rats aged 
8 weeks were obtained from Japan SLC, Inc. (Hamamatsu, Shizuoka, Japan). Rats were ovariectomized four days 
before arrival in our department. The rats were maintained in a temperature- and humidity-controlled room with 
a 12-hour day/night cycle and fed food and water ad libitum.
Dosing regimens and surgical technique. After acclimation for 7 days, they were assigned to two 
groups: (1) ovariectomized rats treated with intermittent parathyroid hormone 1–34 (PTH rats, n = 6); and (2) 
ovariectomized rats given normal saline as vehicle (OVX rats, n = 6). All rats underwent blood extraction and 
surgical procedures (Fig. 1b) under general anesthesia (combination of medetomidine, midazolam and butor-
phanol mixture)21. First, 2 ml of blood was collected from the lateral tail vein of all rats. The rats were then shaved 
and disinfected with 10% povidone iodine. The left surface of the lateral aspect of the mandibular ramus was 
sectioned to the subperiosteal level, and subperiosteal peeling to the lower and posterior margins of the mandible 
was conducted to clearly show the surgical field. At 4 mm from the posterior margin and 2 mm from the lower 
margin on the left aspect of the mandible, a hole was drilled bicortically using a 2-mm diameter pin vise. The 
wound was sutured closed. From one day after the surgical procedure, PTH rats were subcutaneously adminis-
tered PTH (1–34) at 30 μg/kg body weight daily, while OVX rats were subcutaneously administered the same vol-
ume of saline. Twenty-two days after the surgery, all rats were sacrificed under general anesthesia (medetomidine, 
midazolam and butorphanol mixture)21, and 2 ml of blood was collected from the lateral tail vein for analysis of 
oxidation. Subsequently, the mandible and right femur were removed, then stored in a 70% ethanol solution at 4 
°C in preparation for micro-computed tomography (microCT), peripheral quantitative computed tomography 
(pQCT), and Raman analysis.
Analysis of the right femur using microCT. Undecalcified right (Rt.) femur bones (OVX rats, n = 6; 
PTH rats, n = 6) were subjected to three-dimensional microCT (Scan Xmate-A080, Comscan Tecno Co. Ltd. 
Yokohama, Japan) analysis. After the CT images were constructed into three-dimensional images, bone morpho-
metric analysis was conducted with analysis software (TRI/3D-BON, Ratoc System Engineering Co. Ltd. Tokyo, 
Japan). We selected trabecular bone in the distal metaphysis of the femur as sampling site, located 1.5 mm to 
3.5 mm from the growth plate. We measured the morphometric parameters of bone volume (BV/TV; %), trabec-
ular thickness (Tb. Th; μm), trabecular number (Tb. N; 1/mm), and trabecular separation (Tb. Sp; μm).
Analysis of the right femur using pQCT. Undecalcified Rt. femur bones (OVX rats, n = 6; PTH rats, 
n = 6) were evaluated using pQCT, and bone mineral density (BMD; mg/cm3) was measured. Four regions, 
regions 1, 2, 3 and 4, were defined as points at 1, 2, 3 and 12 mm from the growth plate to the diaphysis, 
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respectively. The BMD at these regions was measured using pQCT (Norland/Stratec XCT Research SA+; Stratec 
Medizintechnic GmbH, Pforzheim, Germany).
Analysis of the mandible by microCT. Undecalcified mandibles (OVX rats, n = 6; PTH rats, n = 6) were 
subjected to three-dimensional microCT analysis. After these CT images were constructed into three-dimensional 
images, bone morphometric analysis was conducted using TRI/3D-BON. An 800 μm × 800 μm square from the 
center of the drilled area on the mandible was chosen as sampling site. The same morphometric parameters as 
those for right femur analysis were measured. In addition, images of sagittal sections of the mandible including 
the drilled hole were extracted, and the area of the hole (μm2) was measured using analysis software (Axio Vision 
3.1, Carl Zeiss Co. Ltd, Munich, Germany).
Analysis of the mandible using pQCT. A rectangular region with long edges at a distance of 1.3 mm from 
the center of the drilled hole in the mandible (OVX rats, n = 6; PTH rats, n = 6) was scanned using pQCT, and 
BMD (mg/cm3) was measured.
Mapped image of bone quality of the mandible using Raman microspectroscopy. Undecalcified 
mandibles (OVX rats, n = 6; PTH rats, n = 6) were inspected by Raman microspectroscopy (NRS-5100; Jasco Co. 
Ltd, Tokyo, Japan) after analysis using microCT and pQCT. Before measurement, the mandibles were processed 
in several steps. First, the mandibles were cut using a diamond saw (BS-300C, Meiwafosis Co. Ltd, Tokyo, Japan) 
parallel to the lower mandibular plane so as to pass through the drilled hole. Second, another cut was made ante-
rior to the drilled hole (Fig. 1c). Third, the cut mandible was polished with an Al2O3 polishing disk (MA-200D, 
Misashino Denshi Co. Ltd, Tokyo, Japan), including the center of the hole, to smoothen the cut surface (Fig. 1d). 
Figure 1. Experimental procedure. (a) Experimental protocol. The protocol shows the process up until 
the blood and mandibles were extracted. (b) Surgical procedure. Photographs illustrating the surgical 
procedures used in the mandibular defect rat model. An appropriate area on the left mandible was shaved and 
disinfected with 10% povidone iodine. The left side of the lateral aspect of the mandibular ramus was incised 
to the subperiosteal level, and subperiosteal peeling to the lower and posterior margins of the mandible was 
performed to clearly reveal the surgical field. A point located 4 mm from the posterior margin and 2 mm from 
the lower margin on the left side of the mandible was drilled bicortically using a 2-mm pin vise. The wound 
was closed with sutures. (c) Extracted mandible and cutting line for Raman analysis. First, the mandibles were 
cut using a diamond saw parallel to the lower mandibular plane so as to pass through the drilled hole (red 
line). Second, another cut was made anterior to the drilled hole (blue line). The cut mandible was polished 
with an Al2O3 polishing disk, including the center of the hole, to smoothen the cut surface. (d) Mandible after 
cutting and polishing for Raman analysis. Mandibles after cutting and polishing were subjected to Raman 
analysis. (e) Measurement points for Raman analysis. The outer circumference at a distance of 90 μm from the 
outer periphery of the drilled hole was examined using an optical electron microscope attached to the Raman 
microspectroscope. A straight line (yellow line) connecting the mesial and distal edges of the drilled hole was 
drawn across the smallest diameter, and a second line was drawn perpendicular to the first (green dotted line) 
from outside the 90-μm circumference to the mesial and distal edge of the drilled hole. Four points (red dots) 
along the perpendicular line (green dotted line) were used as measurement points.
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These processed mandibles were subjected to Raman microspectroscopy. The Ar-ion laser power (wavelength: 
532 nm) for these measurements was 100 mW. Raman spectra were measured twice with an acquisition time of 
60 s each, and accumulated. Analysis was limited to the Raman scattering region between 800 and 1800 cm−1. 
Quantitative maps of the distribution of newly formed bone (300 μm × 120 μm) within the sample area, including 
the drilled hole, were obtained using a scanning step size of 10 μm. Further, the outer circumference at a distance 
of 2 mm and 90 μm from the outer periphery of the drilled hole was investigated using an optical electron micro-
scope which was attached to the Raman microspectroscope. A straight line connecting the mesial and distal edges 
of the drilled hole was drawn through the smallest diameter of the hole (Fig. 1e), and another line perpendicular 
to the first was drawn from outside the 90-μm circumference to the mesial and distal bone edges using the Raman 
microspectroscope software (Fig. 1e). Four points on the perpendicular line were used as measurement points of 
90 μm (Fig. 1e). Subsequently, four spectra per specimen were randomly obtained at w2 mm and 90 μm from the 
bone edge around drilled hole. Peaks were assigned and interpreted based on previously described methods18–20. 
The following commonly used Raman bone metrics were calculated at each measurement point:
•	 Mineral/matrix ratio = intensity ratio between v1PO4 (930–980 cm−1) and amide I (1620–1700 cm−1). High 
values indicate more mineralization.
•	 Crystallinity = inverse of the full-width at half-height (FWHH) of the v1PO4 band.
•	 B-type carbonate substitution = intensity ratio between B-type CO32− (1050–1115 cm−1) and v 1PO4 bands. 
High values indicate more B-type carbonate substitution.
•	 Monohydrogen phosphate content = intensity ratio between the v3HPO42−(1003 cm−1) and v 1PO4 bands. 
High values indicate higher levels of calcium phosphate (CaHPO4, CaHPO4 ・ 2H2O).
•	 Collagen structural integrity = intensity ratio of 1640 and 1670 cm−1 in amide I. High values indicate more 
robust collagen structure.
Analysis of serum for assessing oxidant and anti-oxidant stress. The reactive oxygen metabolites 
(d-ROMs) test (Diacron International, Grosseto, Italy) was performed on serum from all rats (n = 12), as reported 
in detail elsewhere22. The d-ROM test was based on levels of serum reactive oxygen metabolites measured using a 
spectrophotometer. The Carratelli unit (CARR U) was used as the measurement unit.
In addition, the OXY-adsorbent test (Diacron International, Grosseto, Italy) was performed on serum from 
all rats as reported in detail elsewhere22. The OXY-adsorbent test is based on total serum anti-oxidant capacity, 
measured using a spectrophotometer. This test evaluates the serum capacity required to oppose the massive oxi-
dative action of a hypochlorous acid (HClO) solution. Total anti-oxidant capacity was expressed as μmol of HClO 
consumed by 1 mL of sample (μmol HClO/mL).
Furthermore, the oxidative-INDEX was calculated from the results of the d-ROM and OXY-adsorbent tests 
to indicate the balance between serum reactive oxygen metabolites and anti-oxidants. To incorporate parameters 
with different measurement units, the standardized values of the ROM and OXY-adsorbent tests were determined 
using the formula developed by Vassale et al.22:
= −‐ ‐ ‐ ‐sv var v var m var sd var( )/
where sv-var is the standardized value of a given parameter, v-var is its original value, and m-var and sd-var are 
the mean and standard deviation of the parameter in both groups (n = 12).
The standardized oxidative-INDEX value was calculated by subtracting the sv-var of the OXY-adsorbent test 
result from the sv-var of the ROM test result. High oxidative-INDEX values indicate high oxidative stress in the 
blood.
Statistical analysis. Statistical analysis was performed using JMP® (version 13.3.0, SAS institute Inc. Cray, 
NC, USA). The statistical data are provided as mean and standard deviation. The t-test was used to compare data 
from experiments using multiple treatments. A p-value less than 0.05 indicated a significant difference.
Results
MicroCT analysis and pQCT for assessing osteoporotic development. MicroCT images of femurs 
from the groups were used to assess various bone morphometric indicators (Fig. 2a). Trabecular data (3D 
microCT) showed that BV/TV and Tb. Th were significantly increased in PTH rats compared to OVX rats, while 
Tb. N an d Tb. Sp were similar between the two groups (Fig. 2b).
To evaluate the effect of PTH on bone calcification, BMD at different regions in the femur was investigated 
using pQCT. BMD was significantly increased in PTH rats compared to OVX rats at regions 1 to 4 (Fig. 2c).
MicroCT analysis to assess the histomorphometry of new mandibular bone. MicroCT images 
of the mandibles from all groups were evaluated to assess various bone morphometric indicators (Fig. 3a). 3D 
microCT data showed that BV/TV and Tb. Th were significantly increased in PTH rats compared to OVX rats, 
while Tb. N and Tb. Sp were similar between the two groups (Fig. 3b). We also measured the area of the drilled 
hole (μm2) by extracting an image from the microCT images in which the area of the drilled hole was minimized 
(Fig. 3c). This analysis showed that the area of the drilled hole was significantly smaller in PTH than OVX rats 
(Fig. 3d).
pQCT analysis of newly formed mandibular bone. To determine the effect of PTH on calcification of 
new bone in the mandible, the BMD in newly formed mandibular bone (Fig. 3e) was measured using pQCT after 
treatment. The BMD of newly formed bone did not significantly differ between groups (Fig. 3f).
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Raman microspectroscopic analysis of newly formed bone of the mandible. The mapped images 
of the mandibles from each group obtained using Raman microspectroscopy were employed to assess various 
indicators of bone quality (Fig. 4a). A mapped image was taken of the sample area, which included the area of 
bone loss and newly formed bone, and colored according to bone quality parameter values within the sample area 
(width × length: 300 μm × 120 μm) using a scanning step size of 10 μm (width × length: 30 × 12 points) (Fig. 4a). 
This analysis indicated that newly formed mandibular bone in PTH rats had reduced mineralization and a dete-
rioration in mineral and collagen quality compared to OVX rats.
Subsequently, to assess bone quality parameters, measurements were performed at four points 90 μm and 
2 mm external to the inner circumference of the hole in the mandible. At 90 μm external to the inner circumfer-
ence of the hole, the mineral/matrix ratio, crystallinity and collagen structural characteristics were significantly 
decreased, and B-type carbonate substitution was significantly increased in PTH compared to OVX rats. No sig-
nificant difference in monohydrogen phosphate content was observed in OVX and PTH rats (Fig. 4b).
At 2 mm external to the inner circumference of the drilled hole, no significant difference was observed in the 
mineral/matrix ratio, crystallinity, monohydrogen phosphate content, B-type carbonate substitution or collagen 
structural integrity (Fig. 4c).
Analysis of oxidation in blood. Serum was collected from rats to examine the degree of oxidation at the 
time of surgery and sacrifice. At the time of surgery, levels of serum reactive oxygen metabolites, total anti-oxidant 
capacity and the oxidative-INDEX did not significantly differ between the groups. At sacrifice, while the levels of 
serum reactive oxygen metabolites did not significantly differ, total anti-oxidant capacity in serum was signifi-
cantly decreased in PTH rats compared to OVX rats and oxidative-INDEX was increased (Fig. 5).
Discussion
While several reports have suggested that PTH improves the bone density and structural characteristics and 
enhances the healing of newly formed jawbone6–9, these studies did not examine the effects of PTH on the mate-
rial characteristics of the newly formed jawbone. Deterioration of material characteristics is known to occur 
through the activation of osteoclasts and increased levels of AGEs due to oxidative stress3,4. We demonstrated that 
PTH improved the bone mass and structural characteristics of newly formed mandibular bone. However, PTH 
administration reduced mineralization and crystallinity while increasing carbonates, and decreased the collagen 
structural integrity of bone matrix of newly formed mandibular bone. Moreover, PTH produced an increase in 
the oxidative-INDEX accompanied by a decrease in anti-oxidative ability. Our findings therefore suggest that 
Figure 2. Assessment of PTH in the treatment of osteoporosis in the right femur. (a) Coronal view of three-
dimensional images of the femur obtained using microCT. The femurs of OVX and PTH rats are shown.  
(b) Parameters of cancellous bone obtained using microCT. Measurements were performed on an area 1.5 to 
3.5 mm proximal to the growth plate at one end of the distal metaphysis of the femur. The target region was 
examined for bone volume (BV/TV), and the thickness (Tb.Th), number (Tb.N), and separation (Tb.Sp) of the 
trabeculae. *P < 0.05. (c) Bone mineral density (BMD) of the femur obtained using pQCT. These values were 
measured at regions 1, 2, 3, and 12 mm proximal to the growth plate. *P < 0.05.
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PTH administration caused a deterioration in the mineral quality and collagen quality of newly formed mandib-
ular bone due to oxidation.
Oxidation increases the levels of AGEs, which decrease bone strength and toughness, and induce osteoclastic 
activity3,4. We found that rats administered PTH showed a decrease in anti-oxidative ability and an increase in the 
oxidative-INDEX. The OXY-adsorbent test measures anti-oxidative ability, which is an indicator of the presence 
of anti-oxidants in the serum. In particular, melatonin, which is secreted from the pineal gland into the blood, 
is known to be a powerful anti-oxidant23. Previous studies have shown an interaction between PTH and mela-
tonin24,25. Specifically, serum melatonin levels changed in inverse proportion to serum PTH levels24. Our present 
results may suggest that daily administration of PTH inhibits the secretion of anti-oxidants like melatonin, which 
may in turn reduce anti-oxidative capacity and increase the oxidative-INDEX. Indeed, serum analysis revealed 
that PTH promoted oxidation while lowering anti-oxidative ability.
Bone is a two-phase composite comprising a mineral phase, which provides stiffness by resisting transforma-
tion, and collagen matrix, which provides toughness and ductility (contractile characteristic) by resisting pressure 
and tension26. The mineral/matrix ratio measured using Raman microspectroscopy can be employed as an index 
of calcification. In rodents, the mineral/matrix ratio correlates well with bending stiffness and breakage point 
of the upper arm, independently of BMD27. In the present study, PTH administration significantly decreased 
the mineral/matrix ratio compared to vehicle administration, suggesting that PTH suppresses mineralization in 
newly formed mandibular bone.
Bone mineral quality is measured by crystallinity, the maturity of crystals and the degree of replacement of 
the crystal structure28. In Raman spectroscopy, mineral quality can be evaluated using three bone quality param-
eters, namely crystallinity, B-type carbonate substitution and monohydrogen phosphate content. Crystallinity, as 
measured using Raman microspectroscopy, is a reflection of both lattice order (completeness of the apatite crystal 
domain) as well as the relative size/distortion of crystals28. B-type carbonate substitution assesses the substitution 
of carbonate ions (CO3−) for phosphoric acid (PO4) in the crystal structure. CO3− has greater solubility than 
PO4 with regard to apatite crystal structure, and is an unstable fraction of bone28,29. Increased B-type carbonate 
substitution is known to be correlated with the distortion of lattice structure, and widens the PO4 band in the 
Raman spectrum, decreasing crystallinity parameter values28. On this basis, the significant increase in B-type 
carbonate and decrease in crystallinity in PTH rats on comparison with OVX rats observed in the present study 
might therefore indicate a distortion of the lattice structure of newly formed bone. In addition, monohydrogen 
phosphate content can be used to measure levels of calcium phosphate (CaHPO4, CaHPO4 · 2H2O), which is 
Figure 3. Analysis of BMD and structural changes in newly formed bone of the mandible. (a) Three-
dimensional images of the mandible obtained using microCT. The mandibles of OVX and PTH rats are shown. 
(b) Parameters of cancellous bone obtained using microCT. Measurement was performed on an area 1.5 to 
3.5 mm proximal to the growth plate located at one end of the distal metaphysis of the femur. The target region 
was examined for bone volume (BV/TV), and the thickness (Tb.Th), number (Tb.N), and separation (Tb.Sp) 
of trabeculae. *P < 0.05. (c) Image of the hole in the mandible extracted from microCT images. An image in 
which the area of the drilled hole was minimized was extracted from microCT images and examined using 
bone analysis software. (d) Area of the hole (μm2) in the mandible obtained using microCT. The area of the 
hole in PTH rats was significantly decreased compared to that in OVX rats. *P < 0.05. (e) Measured area of 
the mandible obtained using pQCT. Image obtained using pQCT showing the measured area of the removed 
mandible 21 days after drilling. Measurement was performed on a rectangular area with long edges at a distance 
of 1.3 mm from the center of the drilled hole. (f) BMD of the newly formed bone in the mandible obtained using 
pQCT. The BMD of newly formed bone was not significantly different between the groups.
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a precursor to the crystal structure of hydroxyapatite. Labile nonaptic domains (HPO4, PO4, CO3), which are 
related to a reduction in bone strength, decrease during bone tissue maturation29, indicating that they are corre-
lated with mineral maturity. In the present study, while there was no difference in the amount of calcium phos-
phate, there was an increase in B-type carbonate substitution in PTH rats, suggesting that the decrease in mineral 
maturity might be induced by an increase in B-type carbonate substitution. These results suggest that ovariectomy 
and PTH influence the mineral quality of newly formed mandibular bone during bone healing.
Bone collagen plays a key role in the toughness of bone26. Raman microspectroscopy is one method used to 
evaluate collagen quality. A peak ratio of 1640/1670 has been previously shown to be suitable for the assessment 
of collagen quality and is reflective of changes in the collagen secondary structure such as collagen crosslinks; 
or more specifically, the transition from an ordered structure to one less ordered20. Oxidative stress is known to 
reduce the collagen structural integrity by enhancing the formation of non-enzymatic collagen crosslinks, which 
are a type of AGE3. In the present study, an increase in the oxidative-INDEX was observed after PTH administra-
tion, indicating a decrease in the completeness of the collagen structure. In addition, Raman microspectroscopy 
demonstrated a deterioration in the collagen structural integrity of PTH rats compared to OVX rats. These results 
may suggest that the production of AGEs following oxidative stress causes a deterioration in collagen crosslinks 
in newly formed bone.
In this experiment, assessment of newly formed bone was done using a 2.0 mm hole. A previous study 
reported that a critical defect size for the mandible of Wistar rats was 4.0 mm30. However, producing a 4.0 mm 
defect may result in damage to the inferior alveolar nerve vascular bundle, which controls sensory innervation of 
Figure 4. Bone quality parameters obtained from Raman spectra. (a) Transmission electron microscopy images 
showing the site used for the mapped image and the mapped images of bone quality parameters. The site used 
for mapping, with spectra obtained at intervals of 10 µm within the 120 µm × 300 µm area, including the drilled 
hole. The mapped images of the mandible were colored based on the value of bone quality parameters from the 
drilled hole to the newly formed bone in OVX and PTH rats. Measured bone quality parameters were mineral/
matrix ratio, full-width at half-height (FWHH) of the v1PO4 band (indicator of crystallinity), monohydrogen 
phosphate content, B-type carbonate substitution, and collagen structural integrity. In these mapped images, 
blue indicates a lower value and red indicates a higher value. Compared to OVX rats, PTH rats showed a 
decrease in the mineral/matrix ratio and collagen structural integrity, and an increase in the FWHH of the 
v1PO4 band and B-type carbonate substitution. (b,c) Bone parameters obtained from Raman spectra. Similar 
to those for the mapped images, measured parameters at 90 μm (b) and 2 mm (c) from the bone edge were 
the mineral/matrix ratio, crystallinity, B-type carbonate substitution, monohydrogen phosphate content, and 
collagen structural integrity in OVX and PTH rats. *P < 0.05.
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the lower lip and mandibular gums. Because this would likely have a substantial impact on the results, we made 
smaller 2.0 mm holes for the cortical size defect. In addition, we confirmed that the holes were not blocked and 
the inferior alveolar nerve vasculature was not injured in all specimens using microCT at the time of sacrifice.
In dental implant treatment, the newly formed bone is interposed between the drilled hole and the implant 
fixture to achieve osteointegration. That is, the performance of dental implant treatment is directly linked to the 
bone quality of the newly formed bone. In particular, the bone quality of newly formed bone at early stages after 
dental implant surgery is very important in the case of immediate implant placement, in which the implant body 
is occluded immediately after tooth extraction and dental implant replacement. Previous studies have demon-
strated that the quality of the mineral and matrix plays a critical role in the stable osteointegration of dental 
implants31,32. As PTH is expected to improve the bone density and microstructure of the bone around the den-
tal implant, researchers are attempting to adapt it for dental implant treatment33,34. However, the quality of the 
newly formed bone mineral and matrix following PTH treatment remains unclear. To our knowledge, the only 
report that has demonstrated the effect of PTH on the material characteristics of newly formed bone examined 
bone quality parameters in a murine tibial fracture model using Raman spectroscopy10. The researchers found 
that administration of 25 μg/kg PTH for two weeks from 8 days after fracture operation decreased B-type car-
bonate substitution but had no effect on matrix quality or collagen orientation10. In contrast, we found that PTH 
improved the bone mass and microstructure of newly formed bone, but caused deterioration in the quality of the 
mineral and matrix. These differences might be explained by differences in the characteristics of jaw and tibial 
bone, the duration of administration, the dose of PTH administered and the ossification types. Unique charac-
teristics of the jawbone include the high loading it encounters and faster bone turnover35. Our present results 
demonstrate that PTH may have a unique effect on newly formed jawbone.
Figure 5. Analysis of serum for assessing oxidant and anti-oxidant stress. At the time of surgery, levels of serum 
reactive oxygen metabolites, total anti-oxidant capacity and the oxidative-INDEX did not significantly differ 
between the groups. At sacrifice, while levels of serum reactive oxygen metabolites did not significantly differ 
between the groups, serum total anti-oxidant capacity was significantly decreased, and the oxidative-INDEX 
was increased in PTH rats compared to OVX rats. *P < 0.05.
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Furthermore, although PTH improves bone mass and structural characteristics, which are advantageous for 
the osteointegration of a dental implant, it causes a deterioration in the quality of the mineral and matrix, thereby 
decreasing bone strength. This is disadvantageous for osteointegration of a dental implant. Therefore, further 
studies are required to adapt PTH to dental implant treatment.
In addition, the mechanism of this adverse impact on mineral and matrix is unclear. We speculate the fol-
lowing. It is known that PTH, which promotes fast bone turnover, promotes an increase in the mass of newly 
formed bone6–9. Mandibular bone is characterized by its faster bone turnover than other skeletal bone35. Together, 
this characteristic and the effect of PTH results in excessive bone turnover in the mandibular bone. In addition, 
this study showed that PTH causes a decrease in serum oxidation by decreasing antioxidant capacity. Oxidation 
causes deterioration in collagen structures and activates osteoclasts3. The combined effect of these factors, 
including the unique characteristics of mandibular bone and oxidation, may result in increased bone mass and 
improved structural characteristics, but also reduced mineralization and deteriorated collagen in newly formed 
mandibular bone.
In conclusion, while intermittent administration of PTH promotes the healing of newly formed mandibular 
bone by improving the microstructure and increasing bone mass, it also promotes oxidation, which depreciates 
the quality of bone minerals and bone collagen. While the outcome of mandibular dental implant treatment 
depends on bone mass and bone quality, osteoporosis worsens bone mass and bone quality in the jaw. It is there-
fore necessary to determine how PTH affects bone quality, which will in turn influence the treatment outcomes 
of jawbone surgeries, including dental implant surgeries, in the future. If changes in bone quality following PTH 
administration can improve the outcome of dental implant treatments, it may be possible to use PTH during 
dental implant treatment for osteoporosis patients.
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